{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:40:27Z","timestamp":1761093627928,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.bcmd.2004.08.025","type":"journal-article","created":{"date-parts":[[2004,12,15]],"date-time":"2004-12-15T21:54:42Z","timestamp":1103147682000},"page":"1-5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["A point mutation in the RNA-binding domain I results in decrease of PKR activation in acute lymphoblastic leukemia"],"prefix":"10.1016","volume":"34","author":[{"given":"Joana M.","family":"Murad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz G.","family":"Tone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liliana R.","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando L.","family":"De Lucca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2004.08.025_bib1","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1089\/jir.1997.17.503","article-title":"The double-stranded RNA-dependent protein kinase: structure and function","volume":"17","author":"Clemens","year":"1997","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.bcmd.2004.08.025_bib2","doi-asserted-by":"crossref","first-page":"11693","DOI":"10.1073\/pnas.96.21.11693","article-title":"Double-stranded RNA-activated protein kinase mediates virus-induced apoptosis: a new role for an old factor","volume":"96","author":"Kaufman","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2004.08.025_bib3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1023\/A:1009664109241","article-title":"Induction of apoptosis by the dsRNA-dependent protein kinase (PKR): mechanism of action","volume":"5","author":"Gil","year":"2000","journal-title":"Apoptosis"},{"key":"10.1016\/j.bcmd.2004.08.025_bib4","doi-asserted-by":"crossref","first-page":"6112","DOI":"10.1038\/sj.onc.1203127","article-title":"PKR: a sentinel kinase for cellular stress","volume":"18","author":"Williams","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.bcmd.2004.08.025_bib5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1357-2725(98)00136-8","article-title":"PKR, apoptosis and cancer","volume":"31","author":"Jagus","year":"1999","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bcmd.2004.08.025_bib6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/nar\/29.1.189","article-title":"The non-coding RNAs as riboregulators","volume":"29","author":"Erdmann","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bcmd.2004.08.025_bib7","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1007\/PL00000913","article-title":"Regulatory RNAs","volume":"58","author":"Erdmann","year":"2001","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bcmd.2004.08.025_bib8","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/embo-reports\/kve230","article-title":"Non-coding RNAs: the architects of eukaryotic complexity","volume":"2","author":"Mattick","year":"2001","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bcmd.2004.08.025_bib9","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/35103511","article-title":"Non-coding RNA genes and the modern RNA world","volume":"2","author":"Eddy","year":"2001","journal-title":"Nat. Rev., Genet."},{"key":"10.1016\/j.bcmd.2004.08.025_bib10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0014-2999(02)02072-1","article-title":"Activation of RNA-dependent protein kinase and nuclear factor-kappa B by regulatory RNA from lipopolysaccharide-stimulated macrophages: implications for cytokine production","volume":"450","author":"De Lucca","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcmd.2004.08.025_bib11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1023\/A:1019983102017","article-title":"Evidence for the involvement of the RNA-dependent protein kinase (PKR) in the induction of human cytotoxic T lymphocytes against a synthetic peptide of HIV-1 by regulatory RNA","volume":"238","author":"De Lucca","year":"2002","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bcmd.2004.08.025_bib12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1023\/A:1024107512419","article-title":"Regulatory RNA induces the production of IFN-\u03b3, but not IL-4 in human lymphocytes: role of RNA-dependent protein kinase (PKR) and NF-\u03baB","volume":"247","author":"De Lucca","year":"2003","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bcmd.2004.08.025_bib13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0014-2999(03)01480-8","article-title":"Anti-tumor activity induced by regulatory RNA: possible role of RNA-dependent protein kinase and nuclear factor-\u03baB","volume":"465","author":"Watanabe","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcmd.2004.08.025_bib14","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/0092-8674(93)90320-P","article-title":"Tumor suppression by RNA from the 3\u2032-untranslated region alpha-tropomyosin","volume":"17","author":"Rastinejad","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.bcmd.2004.08.025_bib15","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1073\/pnas.93.1.508","article-title":"In vitro activation of the interferon-induced, double-stranded RNA-dependent protein kinase PKR by RNA from 3\u2032-untranslated regions of human \u03b1-tropomyosin","volume":"93","author":"Davis","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2004.08.025_bib16","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/nar\/30.5.1205","article-title":"The 3\u2032-untranslated regions cytoskeletal muscle mRNAs inhibit translation by activating the double-stranded RNA-dependent protein kinase","volume":"30","author":"Nussbaum","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bcmd.2004.08.025_bib17","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1128\/MCB.15.6.3138","article-title":"Mutants of RNA-dependent protein kinase (PKR) lacking double-stranded RNA binding domain I can act as transdominant inhibitors and induce malignant transformation","volume":"15","author":"Barber","year":"1995","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bcmd.2004.08.025_bib18","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1002\/j.1460-2075.1992.tb05200.x","article-title":"Human P68 kinase exhibits growth suppression in yeast and homology to the translational regulator GCN2","volume":"11","author":"Chong","year":"1992","journal-title":"EMBO J."},{"key":"10.1016\/j.bcmd.2004.08.025_bib19","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1074\/jbc.270.6.2601","article-title":"Mutational analysis of the double-stranded RNA (dsRNA) binding domain of the dsRNA-activated protein kinase PKR","volume":"270","author":"McMillan","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcmd.2004.08.025_bib20","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1159\/000133022","article-title":"Report of the committee on chromosome changes in neoplasia","volume":"55","author":"Mitelman","year":"1990","journal-title":"Cytogenet. Cell Genet."},{"key":"10.1016\/j.bcmd.2004.08.025_bib21","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1006\/excr.1998.4201","article-title":"The murine PKR tumor suppressor gene is rearranged in a lymphocytic leukemia","volume":"244","author":"Abraham","year":"1998","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bcmd.2004.08.025_bib22","first-page":"1593","article-title":"Expression of the protein kinase PKR is modulated by IRF-1 and is reduced in 5q-associated leukemias","volume":"12","author":"Beretta","year":"1996","journal-title":"Oncogene"},{"key":"10.1016\/j.bcmd.2004.08.025_bib23","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/ijc.11714","article-title":"Loss of PKR activity in chronic lymphoblastic leukemia","volume":"109","author":"Hu","year":"2004","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bcmd.2004.08.025_bib24","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1021\/bi0120594","article-title":"Identification of binding sites for both dsRBMs of PKR on kinase-activing and kinase-inhibiting RNA ligands","volume":"41","author":"Spanggord","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcmd.2004.08.025_bib25","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1128\/MCB.19.4.2475","article-title":"Double-stranded-RNA-activated protein kinase PKR enhances transcriptional activation by tumor suppressor p53","volume":"19","author":"Cuddihy","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bcmd.2004.08.025_bib26","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1017\/S1355838202022586","article-title":"The mRNA of the translationally controlled tumor protein P23\/TCTP is a highly structured RNA, which activates the dsRNA-dependent protein kinase PKR","volume":"8","author":"Bommer","year":"2002","journal-title":"RNA"}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979604001822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979604001822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:21:31Z","timestamp":1761049291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979604001822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S1079979604001822"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2004.08.025","relation":{},"ISSN":["1079-9796"],"issn-type":[{"type":"print","value":"1079-9796"}],"subject":[],"published":{"date-parts":[[2005,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A point mutation in the RNA-binding domain I results in decrease of PKR activation in acute lymphoblastic leukemia","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2004.08.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}